remind me again, how many times you've been suspended. I have lost count and calling my posts amazing. you've ruined this thread with your relentless misleading posts without knowing facts. People now dont want to even contribute or entertain
- Forums
- ASX - By Stock
- NYR
- Ann: Phase I Clinical Trial Dosing Update No 3
NYR
nyrada inc.
Add to My Watchlist
0.00%
!
23.5¢

Ann: Phase I Clinical Trial Dosing Update No 3, page-36
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.62M |
Open | High | Low | Value | Volume |
23.5¢ | 26.5¢ | 23.5¢ | $270.0K | 1.105M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49900 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 19000 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 60000 | 0.235 |
1 | 20047 | 0.230 |
1 | 50000 | 0.225 |
5 | 88773 | 0.220 |
2 | 120005 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 19000 | 3 |
0.245 | 199738 | 2 |
0.250 | 10000 | 1 |
0.255 | 33711 | 2 |
0.260 | 4500 | 1 |
Last trade - 15.01pm 18/06/2025 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online